register free | resend password


Relaunch of the Xenios Website - now harmonized with that of its parent, Fresenius Medical Care

ID: 1548666
recent pressrelease next pressrelease

(PresseBox) - The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent. www.xenios-ag.com

With this newly structured website, the medical technology company based in Heilbronn, Germany, has managed to create a well-structured, state-of-the-art information and learning platform to aid doctors, customers and business partners. The main focus of the redesign aimed at producing a user-friendly site that would provide fast and easy access to important product and therapy information.

Xenios Campus, the e-learning platform of the Xenios AG, was newly configured at the same time. Users are now able to find learning and therapy content they need with just a few clicks.

"With this relaunch, we are not only directly addressing and satisfying the needs of our business partners, we are also taking a major step towards integrating our products and therapies into the parent company, Fresenius Medical Care," confirms Xenios AG CEO Dr. Andreas Terpin.

The relaunch was presented to an audience of medical professionals attending the EuroELSO Congress in Barcelona, from 10th to 13th April.

Xenios AG - a company of the Fresenius Medical Care Group - is a pioneer in extracorporeal heart and lung support. The Novalung and Medos products offer a wide range of heart and lung support products via a single platform, the Xenios console.

Xenios mission is to improve patient well-being and care. The Novalung therapy aims at a paradigm shift in lung support: enabling the treatment of patients that are awake, self-determined and mobile.

Xenios AG has been part of Fresenius Medical Care, the world''s leading provider of products and services for people with kidney disease since the end of 2016. Xenios complements the group''s portfolio in the area of holistic multi-organ support of FME.



Visit the new website of Xenios AG:

www.xenios-ag.com



More information:
http://thehive44.com https://www.annotatedbibliographyapa.net/ https:// https://maddenmobilechampions.com/ https://



Keywords (optional):



Company information / Profile:

Xenios AG - a company of the Fresenius Medical Care Group - is a pioneer in extracorporeal heart and lung support. The Novalung and Medos products offer a wide range of heart and lung support products via a single platform, the Xenios console.Xenios mission is to improve patient well-being and care. The Novalung therapy aims at a paradigm shift in lung support: enabling the treatment of patients that are awake, self-determined and mobile.Xenios AG has been part of Fresenius Medical Care, the world''s leading provider of products and services for people with kidney disease since the end of 2016. Xenios complements the group''s portfolio in the area of holistic multi-organ support of FME.Visit the new website of Xenios AG:www.xenios-ag.com

PressRelease by

Requests:



PressContact / Agency:



published by: PresseBox
print pressrelease  send to a friend  

Date: 04/18/2019 - 14:27
Language: English
News-ID 1548666
Character count: 2481
Kontakt-Informationen:
Firma: Xenios AG
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Heilbronn
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 1111

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 347
Register today: 0
Register yesterday: 1
Members online: 0
Guests online: 60


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Categories:


[ more PressReleases ][ RSS-Feed ]